Directed issue of shares in Active Biotech (SE) — SEK 340 million Healthcare Directed issue of shares in Active Biotech (SE) — SEK 340 million
Secondary offering of shares in Kalmar Industries (SE) — SEK 305 million Industrials Secondary offering of shares in Kalmar Industries (SE) — SEK 305 million
Initial public offering of Tryckinvest i Norden AB ("Tina") (SE) — SEK 1.2 billion TMT Initial public offering of Tryckinvest i Norden AB ("Tina") (SE) — SEK 1.2 billion
New share issue in Sendit AB (SE) — SEK 75 million TMT New share issue in Sendit AB (SE) — SEK 75 million
Directed share issue in MiniDoc AB (SE) — SEK 25 million Healthcare Directed share issue in MiniDoc AB (SE) — SEK 25 million
Acquisition of Lund Research Center (SE) by Active Biotech AB (SE) from Pharmacia & Upjohn (US) — SEK 380 million Healthcare Acquisition of Lund Research Center (SE) by Active Biotech AB (SE) from Pharmacia & Upjohn (US) — SEK 380 million
Divestment of NTS (SE) by Ratos (SE) to DanTransport (DK) — Amount not disclosed. Transportation & Shipping Divestment of NTS (SE) by Ratos (SE) to DanTransport (DK) — Amount not disclosed.
Acquisition of CarPark (SE) by UBS Capital B.V. (NL) — Amount not disclosed. Real Estate Acquisition of CarPark (SE) by UBS Capital B.V. (NL) — Amount not disclosed.
Secondary offering in Intentia (SE) — SEK 550 million TMT Secondary offering in Intentia (SE) — SEK 550 million
Initial public offering of Prevas (SE) — SEK 94 million TMT Initial public offering of Prevas (SE) — SEK 94 million
Rights issue in Active Biotech (SE) — SEK 255 million Healthcare Rights issue in Active Biotech (SE) — SEK 255 million
New share issue in Intentia (SE) — SEK 520 million TMT New share issue in Intentia (SE) — SEK 520 million